Daniel E. Geffken Phoenix Biotech Acquisition Corp. (PBAXU) insider trading activity

PBAXU Quotes by TradingView

Daniel E. Geffken is Chief Financial Officer of PHOENIX BIOTECH ACQUISITION CORP.. Currently has a direct ownership of 10,002 shares of PBAXU, which is worth approximately $0. The most recent transaction as insider was on Feb 14, 2024, when has been sold 10,002 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10K
0% 3M change
n/a 12M change
Total Value Held $0

Daniel E. Geffken Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 14 2024
BUY
Other acquisition or disposition
-
10,002 Added 50.0%
10,002 Class A Common Stock

Also insider at

EFTR
eFFECTOR Therapeutics, Inc. Healthcare
Chief Financial Officer
WINT
WINDTREE THERAPEUTICS INC Healthcare
Director
ELOX
Eloxx Pharmaceuticals, Inc. Healthcare
INTERIM CFO
GRAY
GRAYBUG VISION, INC. Healthcare
Interim CFO
PMN
ProMIS Neurosciences Inc.
Chief Financial Officer
DEG

Daniel E. Geffken

Chief Financial Officer
Philadelphia, PA

Track Institutional and Insider Activities on PBAXU

Follow PHOENIX BIOTECH ACQUISITION CORP. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PBAXU shares.

Notify only if

Insider Trading

Get notified when an Phoenix Biotech Acquisition Corp. insider buys or sells PBAXU shares.

Notify only if

News

Receive news related to PHOENIX BIOTECH ACQUISITION CORP.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PBAXU